4 active trials 0 recruiting 1 Phase 3 1 disease areas
| Phase 1/2 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT04498117 | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer… | Carcinoma, Ovarian Epithelial | Active, Not Recruiting | 2026-04-01 |
| Phase 2 | ||||
| NCT05335993 | A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With… | Recurrent Ovarian Cancer | Active, Not Recruiting | 2026-04-03 |
| NCT05605535 | Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With… | Ovarian Neoplasm Epithelial | Active, Not Recruiting | 2026-04-01 |
| Phase 1/2 | ||||
| NCT04938583 | Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum… | Ovarian Cancer by FIGO Stage | Active, Not Recruiting | 2026-04-06 |
Ovarian Cancer (4)